title: Pharmacotherapy for Neurodegenerative Diseases: Are We Approaching the Tipping Point?
abstract: Neurodegenerative diseases continue to represent major unmet medical and public health needs and will increasingly strain the healthcare system as people live longer due to medical advances in other diseases. Hopefully the emergence of increased understanding of the biology of these conditions coupled with novel clinical pharmacology tools, clinical trial designs, and regulatory innovation will allow the emergence of highly effective symptomatic and disease modifying pharmacotherapies.
authors.affiliation: Collegeville, Pennsylvania, USA.
authors.forename: P K
authors.initials: PK
authors.lastname: Honig
mesh_terms: D004358:Drug Therapy / Q000639:trends*; D006301:Health Services Needs and Demand / Q000639:trends*; D006801:Humans; D019636:Neurodegenerative Diseases / Q000175:diagnosis / Q000188:drug therapy*